• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    OptimizeRx Corporation - Common Stock (NQ:OPRX)

    6.780 +0.080 (+1.19%)
    Streaming Delayed Price Updated: 3:48 PM EDT, May 4, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about OptimizeRx Corporation - Common Stock

    < Previous 1 2 3 Next >
    News headline image
    OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing
    Life science marketers will be able to better measure the exposed audiences for a more complete, accurate, and transparent view of campaign engagement and effectiveness 
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
    Strategic Partnerships Add Exclusivity in Leading EHR, e-Prescription, and Technology Companies, Increasing NPI Reach by 37% 
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions
    From Simulmedia
    Via Business Wire
    News headline image
    OptimizeRx to Participate in Upcoming Investor Conferences
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
    No Stockholder Action Required at this Time 
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer
    Silvestro has a demonstrated record of accelerating revenue growth, expanding brand relevance, and building a market-leading team 
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx to Participate in Upcoming Investor Conferences
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Reports Third Quarter 2024 Financial Results
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
    From OptimizeRx Corporation
    Via GlobeNewswire
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.